Search research articles
Contact Us
Filters
Showing results (141-150 of 171) with videos related to
Page
of 18
Sort By:
Journal of Clinical Pathology
|
June 29, 2004
Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma
M R Morris, E Maina, N V Morgan, et al.
Journal of Medical Genetics
|
February 1, 1996
A genetic register for von Hippel-Lindau disease
I R Maddock, A Moran, E R Maher, et al.
British Journal of Cancer
|
October 27, 2004
Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma
D Astuti, M Morris, C Krona, et al.
Nature
|
June 3, 1999
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
P H Maxwell, M S Wiesener, G W Chang, et al.
Oncogene
|
December 7, 2010
Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma
M R Morris, C J Ricketts, D Gentle, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
March 21, 2013
Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis
S C Hillman, D J McMullan, G Hall, et al.
Surgery
|
December 15, 2000
Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease
S K Libutti, P L Choyke, H R Alexander, et al.
Oncogene
|
September 27, 2006
Identification of novel VHL targets that are associated with the development of renal cell carcinoma
M Abdulrahman, E N Maina, M R Morris, et al.
Human Genetics
|
August 21, 2001
Opposite association of two PPARG variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and underrepresentation of P12A in renal cell carcinoma cases
W M Smith, X P Zhou, K Kurose, et al.
Cancer Research
|
October 5, 2001
Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma
C Morrissey, A Martinez, M Zatyka, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 171) with videos related to
Sort By:
Page
of 18
Journal of Clinical Pathology
|
June 29, 2004
Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma
M R Morris, E Maina, N V Morgan, et al.
Journal of Medical Genetics
|
February 1, 1996
A genetic register for von Hippel-Lindau disease
I R Maddock, A Moran, E R Maher, et al.
British Journal of Cancer
|
October 27, 2004
Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma
D Astuti, M Morris, C Krona, et al.
Nature
|
June 3, 1999
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
P H Maxwell, M S Wiesener, G W Chang, et al.
Oncogene
|
December 7, 2010
Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma
M R Morris, C J Ricketts, D Gentle, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
March 21, 2013
Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis
S C Hillman, D J McMullan, G Hall, et al.
Surgery
|
December 15, 2000
Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease
S K Libutti, P L Choyke, H R Alexander, et al.
Oncogene
|
September 27, 2006
Identification of novel VHL targets that are associated with the development of renal cell carcinoma
M Abdulrahman, E N Maina, M R Morris, et al.
Human Genetics
|
August 21, 2001
Opposite association of two PPARG variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and underrepresentation of P12A in renal cell carcinoma cases
W M Smith, X P Zhou, K Kurose, et al.
Cancer Research
|
October 5, 2001
Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma
C Morrissey, A Martinez, M Zatyka, et al.
Page
of 18